GenomOncology and Genomenon Partner to Enhance Germline Variant Classification
Slice of Healthcare Team
11/08/2024
Key Highlights
- GenomOncology integrates Genomenon's Mastermind Data to improve germline variant classification.
- Partnership aims to enhance genomic reporting for clinicians in cancer and rare disease treatment.
- Genomenon’s AI-powered genomic data aligns with ACMG guidelines and ClinGen standards.
- Enables comprehensive and precise germline clinical reporting for healthcare providers.
Source: PR Newswire
Notable Quotes
“ This partnership represents a significant step forward in our mission to empower healthcare providers with high-quality genomic data. ”
Mike Klein, CEO at Genomenon
“ Access to Genomenon's Mastermind Data is a game changer for our clients. ”
Garreth Hippe, CCO at GenomOncology
